Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 4.95 GBp
Change Today 0.00 / 0.00%
Volume 201.7K
VRP On Other Exchanges
Symbol
Exchange
OTC US
Frankfurt
As of 11:21 AM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Clive P. Page BSc,Ph.D.

Former Non-Executive Chairman, President and Chairman of Nomination & Corporate Governance Committee, Verona Pharma plc
AgeTotal Calculated CompensationThis person is connected to 15 board members in 3 different organizations across 7 different industries.

See Board Relationships
----

Background*

Prof. Clive P. Page, B Sc, PhD, has been a Professor and Head of the Sackler Institute of Pulmonary Pharmacology at the School of Biomedical Sciences, King's College, University of London since 1994 and a Consultant to the pharmaceutical industry. Prof. Page served as the President and Senior Scientific Officer of Verona Pharma Plc (formerly known as Rhinopharma Limited). He is recognized as a World Expert in asthma and other inflammatory diseases and has published widely ...

Read Full Background

Corporate Headquarters*

3 More London Riverside
London, Greater London SE1 2RE

United Kingdom

Phone: 44 20 3283 4200
Fax: --

Board Members Memberships*

Former Non Executive Chairman
2006-2014
Former Non-Executive Chairman, President and Chairman of Nomination & Corporate Governance Committee

Education*

PhD 1984
King's College London

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRP:LN 4.95 GBp 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Clive A. Meanwell M.D., Ph.D.Chairman and Chief Executive Officer
The Medicines Company
$874.6K
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
$1.5M
Albert David Friesen Ph.D.Founder, Chairman and Chief Executive Officer
Medicure Inc.
C$105.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERONA PHARMA PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.